Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Clinical trial NCT05947669 · RECRUITING
Trial details
- NCT number
- NCT05947669
- Sponsor
- Odense University Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-22
- Primary completion
- 2026-09-01
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.